Impact Biomedical Income Statement (2022-2026) | IBO

Income Statement Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter) 0.05M0.01M0.02M0.01M
Cost of Revenue (Quarter) 0.01M0.00M
Gross Profit (Quarter) -0.00M0.02M
Operating items
Research & Development (Quarter) 0.21M0.33M0.52M0.26M0.01M0.02M-0.99M0.18M0.02M0.46M-0.21M0.02M0.00M0.00M0.00M
Selling, General & Administrative (Quarter) 0.06M0.09M0.04M0.04M0.04M0.10M0.13M0.15M0.14M0.13M-0.07M0.25M0.25M0.26M-0.44M1.62M
Restructuring Costs (Quarter) 0.03M0.01M0.03M0.01M0.02M0.12M
Other Operating Expenses (Quarter) 0.51M0.46M0.44M0.51M0.94M0.94M1.87M0.44M0.46M0.53M26.51M0.74M0.91M0.70M0.68M
Operating Expenses (Quarter) 0.80M0.89M1.03M0.80M1.01M1.08M1.14M0.77M0.63M1.13M26.23M1.01M1.16M0.97M-0.44M2.30M
Operating Income (Quarter) -0.75M-0.89M-1.03M-0.80M-1.01M-1.08M-1.14M-0.77M-0.63M-1.13M-26.23M-1.01M-1.15M-0.95M-2.29M
EBIT (Quarter) -0.75M-0.89M-1.03M-0.80M-1.01M-1.08M-1.14M-0.77M-0.63M-1.13M-26.23M-1.01M-1.15M-0.95M-2.29M
Non-operating items
Interest & Investment Income (Quarter) 0.09M0.00M-0.08M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.01M
Other Non Operating Income (Quarter) 0.05M5.67M
Non Operating Income (Quarter) 0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Net income details
EBT (Quarter) -0.80M-0.98M-5.25M-0.85M-1.12M-1.18M-1.26M-1.00M-0.88M4.24M-27.10M-1.28M-14.35M-1.48M-2.28M
Tax Provisions (Quarter) 1.26M-1.88M
Profit After Tax (Quarter) -0.80M-2.24M-3.37M-0.85M-1.12M-1.18M-1.26M-1.00M-0.88M4.25M-27.11M-1.28M-14.35M-1.47M-2.29M
Income from Non-Controlling Interests (Quarter) -0.07M-0.07M0.20M-0.19M-0.02M-0.01M-0.03M-0.04M0.01M-0.01M-0.03M-0.01M-0.01M-0.01M0.00M
Income from Continuing Operations (Quarter) -0.80M-2.24M-3.37M-0.85M-1.12M-1.18M-1.26M-1.00M-0.88M4.24M-27.10M-1.28M-14.35M-1.48M-2.28M
Consolidated Net Income (Quarter) -0.80M-2.24M-3.37M-0.85M-1.12M-1.18M-1.26M-1.00M-0.88M4.24M-27.10M-1.28M-14.35M-1.48M-2.28M
Income towards Parent Company (Quarter) -0.80M-2.24M-3.37M-0.85M-1.12M-1.18M-1.26M-1.00M-0.88M4.24M-27.10M-1.28M-14.35M-1.48M-2.28M
Net Income towards Common Stockholders (Quarter) -0.73M-2.17M-3.36M-0.66M-1.10M-1.16M-1.24M-0.96M-0.89M4.25M-27.10M-1.28M-14.35M-1.48M-2.28M
Additional items
EPS (Basic) (Quarter) -0.01-0.03-0.05-0.01-0.02-0.02-0.02-0.10-0.090.06-2.52-0.11-1.18-0.12-0.02
Shares Outstanding (Quarter) 70.49M70.50M70.50M70.50M70.49M70.50M60.25M10.00M10.00M72.00M10.76M12.06M12.19M12.19M31.55M107.79M
Shares Outstanding (Entity) (Quarter) 70.49M70.50M70.49M70.50M70.49M70.50M60.25M10.00M10.00M72.00M11.50M12.09M12.19M12.19M31.55M107.82M
EBITDA (Quarter) -0.75M-0.89M-1.03M-0.80M-1.01M-1.08M-1.14M-0.77M-0.63M-1.13M-26.23M-1.01M-1.15M-0.95M-2.29M
Interest Expenses (Quarter) 0.14M0.09M0.10M0.10M1.11M1.11M0.12M1.11M1.11M1.11M0.27M1.28M1.28M1.13M0.42M11.04M
Tax Rate (Quarter) -128.63%35.82%